Antivirals, Including Antibody Products
These sections summarize data on the use of antiviral agents for the treatment of COVID-19.
Recommendations for the use of antiviral agents to treat COVID-19
Information on the use of intravenous remdesivir as treatment for COVID-19
Drug interactions and other considerations for the use of ritonavir-boosted nirmatrelvir (Paxlovid)
Information on molnupiravir as an alternative therapy for some nonhospitalized patients with COVID-19
Information on monoclonal antibodies that target the SARS-CoV-2 spike protein
Information on high-titer plasma from donors who have recovered from COVID-19
Information on the use of interferons in patients with COVID-19
Characteristics of antiviral agents evaluated in COVID-19 clinical trials